Cresanto Global Limited

₹5.37As of Sun 8 Nov 2026, 12:00 UTC
BSE:531207Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 6.53%
Div yield —
ROE —
Pharmaceutical Preparations
Beta (5Y) 0.04
PE TTM —
TSR TTM —
Mkt cap ₹22.95M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹5.55
3.37%
42.17%
Hold 10|8|10|5|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.05
0.06
0.06
0.06
19.54%
20.80%
11.47%
24.93%
Revenue₹M
2.540
2.673
2.642
2.772
5.13%
10.68%
6.86%
13.54%
Peers (US$0.244M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.207
0.096
0.095
EBIT/Intx
9.738
0.233
0.234
Own earn%
(0.51)
(10.38)
(17.99)
Sh yield%
30.34
11.86
12.03
Owners
Insiders/Inst%
10.83
87.28
Short interest%
4.15
SBC / revenue%
0.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
7–17
$1 testx
—
Incr. ROIC%
3